The substantia nigra of the human brain: II. Patterns of loss of dopamine-containing neurons in Parkinson's disease

Brain

Volumn 122, Issue 8, 1999, Pages 1437-1448

  Damier, P ^a,b   Hirsch, E C ^a   Agid, Y ^a   Graybiel, A M ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Basal ganglia; Calbindin; Dopamine; Parkinson's disease; Substantia nigra

Indexed keywords

CALBINDIN;

AGED; ARTICLE; CELL LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DOPAMINERGIC NERVE CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL DEGENERATION; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

EID: 0032816549     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/122.8.1437     Document Type: Article

References (23)

1. Abercrombie M. Estimation of nuclear population from microtome sections. Anat Rec 1946; 94: 239-47.
2. Brooks DJ, Ibanez V, Sawle GV, Quinn N, Lees AJ, Mathias CJ, et al. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy [see comments]. Ann Neurol 1990; 28: 547-55. Comment in: Ann Neurol 1991; 29: 689-90.
3. Brooks DJ, Ibanez V, Sawle GV, Quinn N, Lees AJ, Mathias CJ, et al. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy [see comments]. Ann Neurol 1990; 28: 547-55. Comment in: Ann Neurol 1991; 29: 689-90.
4. 28K immunohistochemistry. Brain 1999; 122: 1421-36.
5. Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991; 114: 2283-301.
6. 11C-Win 35,428 reveals marked declines in mild Parkinson's disease [see comments]. Ann Neurol 1993; 34: 423-31. Comment in: Ann Neurol 1994; 35: 376-9.
7. 11C-Win 35,428 reveals marked declines in mild Parkinson's disease [see comments]. Ann Neurol 1993; 34: 423-31. Comment in: Ann Neurol 1994; 35: 376-9.
8. German DC, Manaye K, Smith WK, Woodward DJ, Saper CB. Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization [see comments]. Ann Neurol 1989; 26: 507-14. Comment in: Ann Neurol 1990; 28: 111-2.
9. German DC, Manaye K, Smith WK, Woodward DJ, Saper CB. Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization [see comments]. Ann Neurol 1989; 26: 507-14. Comment in: Ann Neurol 1990; 28: 111-2.
10. Hassler R. Zur Pathologie der paralysis agitans und des postenzephalitischen Parkinsonismus. J Psychol Neurol 1938; 48: 387-176.
11. Hirsch EC, Graybiel AM, Agid YA. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 1988; 334: 345-8.
12. Ito H, Goto S, Sakamoto S, Hirano A. Calbindin-D28 in the basal ganglia of patients with Parkinsonism. Ann Neurol 1992; 32: 543-50.
13. Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med 1988; 318: 876-80.
14. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism [see comments]. Nature 1998; 392: 605-8. Comment in: Nature 1998; 392: 544-5.
15. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism [see comments]. Nature 1998; 392: 605-8. Comment in: Nature 1998; 392: 544-5.
16. Mann DM, Yates PO, Marcyniuk B. Dopaminergic neurotransmitter systems in Alzheimer's disease and in Down's syndrome at middle age. J Neurol Neurosurg Psychiatry 1987; 50: 341-4.
17. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease [see comments]. Science 1997; 276: 2045-7. Comment in: Science 1997; 276; 1973, Comment in: Science 1997; 278; 1212-3, Comment in: Science 1998; 279: 116-7, Comment in: Science 1998; 280: 175.
18. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease [see comments]. Science 1997; 276: 2045-7. Comment in: Science 1997; 276; 1973, Comment in: Science 1997; 278; 1212-3, Comment in: Science 1998; 279: 116-7, Comment in: Science 1998; 280: 175.
19. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease [see comments]. Science 1997; 276: 2045-7. Comment in: Science 1997; 276; 1973, Comment in: Science 1997; 278; 1212-3, Comment in: Science 1998; 279: 116-7, Comment in: Science 1998; 280: 175.
20. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease [see comments]. Science 1997; 276: 2045-7. Comment in: Science 1997; 276; 1973, Comment in: Science 1997; 278; 1212-3, Comment in: Science 1998; 279: 116-7, Comment in: Science 1998; 280: 175.
21. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease [see comments]. Science 1997; 276: 2045-7. Comment in: Science 1997; 276; 1973, Comment in: Science 1997; 278; 1212-3, Comment in: Science 1998; 279: 116-7, Comment in: Science 1998; 280: 175.
22. Schelosky L, Poewe W. Topographical onset and progression of motor symptoms in idiopathic Parkinson's disease. Mov Disord 1990; 5 (Suppl 1): 13.
23. Vidailhet M, Bonnet AM, Marconi R, Gouider-Khouja N, Agid Y. Do parkinsonian symptoms and levodopa-induced dyskinesias start in the foot? Neurology 1994; 44: 1613-6.